Phase 1 Advanced malignant solid tumors Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
CT-95 in Advanced Cancers Associated With Mesothelin Expression
Mesothelin-Expressing TumorsEpithelial Ovarian CancerLung Adenocarcinoma Metastatic+7 more
Context Therapeutics Inc.70 enrolled8 locationsNCT06756035
Recruiting
Phase 1
MT027 in Patients With Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors
B7-H3-positive Advanced Malignant Solid Tumors Advanced Primary Peritoneal Tumors or Secondary Abdominal Metastatic Malignant Solid Tumors
Zhejiang University12 enrolled1 locationNCT06912152
Recruiting
Phase 1
Anti-CDH17 CAR-T Cell Injection in Patients With CDH17-positive Advanced Malignant Solid Tumors
CDH17-positive Advanced Malignant Solid Tumors
Shanghai Pudong Hospital17 enrolled1 locationNCT06501183
Terminated
Phase 1
A first-in-human study of VG161 in participants with advanced malignant tumours that have not responded to conventional therapies.
Advanced malignant solid tumors
Virogin Biotech Australia Pty. Ltd.36 enrolled3 locationsACTRN12620000244909